Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;21(3):452-459.
doi: 10.1002/wps.21020.

Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study

Affiliations

Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study

Lin Li et al. World Psychiatry. 2022 Oct.

Abstract

Accumulating evidence suggests a higher risk for cardiovascular diseases among individuals with mental disorders, but very little is known about the risk for overall and specific groups of cardiovascular diseases in people with attention-deficit/hyperactivity disorder (ADHD). To fill this knowledge gap, we investigated the prospective associations between ADHD and a wide range of cardiovascular diseases in adults. In a nationwide population-based cohort study, we identified 5,389,519 adults born between 1941 and 1983, without pre-existing cardiovascular diseases, from Swedish registers. The study period was from January 1, 2001 to December 31, 2013. Incident cardiovascular disease events were identified according to ICD codes. Hazard ratios (HR) with 95% confidence intervals (CI) were calculated using Cox proportional hazards regression model, with ADHD as a time-varying exposure. After an average 11.80 years of follow-up, 38.05% of individuals with ADHD versus 23.57% of those without ADHD had at least one diagnosis of cardiovascular disease (p<0.0001). ADHD was significantly associated with increased risk of any cardiovascular disease (HR=2.05, 95% CI: 1.98-2.13) after adjusting for sex and year of birth. Further adjustments for education level, birth country, type 2 diabetes mellitus, obesity, dyslipidemia, sleep problems and heavy smoking attenuated the association, which however remained significant (HR=1.84, 95% CI: 1.77-1.91). Further adjustment for psychiatric comorbidities attenuated but could not fully explain the association (HR=1.65, 95% CI: 1.59-1.71). The strongest associations were found for cardiac arrest (HR=2.28, 95% CI: 1.81-2.87), hemorrhagic stroke (HR=2.16, 95% CI: 1.68-2.77), and peripheral vascular disease/arteriosclerosis (HR=2.05, 95% CI: 1.76-2.38). Stronger associations were observed in males and younger adults, while comparable associations were found among individuals with or without psychotropic medications and family history of cardiovascular diseases. These data suggest that ADHD is an independent risk factor for a wide range of cardiovascular diseases. They highlight the importance of carefully monitoring cardiovascular health and developing age-appropriate and individualized strategies to reduce the cardiovascular risk in individuals with ADHD.

Keywords: Attention-deficit/hyperactivity disorder; arteriosclerosis; cardiac arrest; cardiovascular diseases; hemorrhagic stroke; peripheral vascular disease; psychiatric comorbidities; psychotropic medications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hazard ratio (HR) with 95% CI of developing different types of cardiovascular diseases among adults with attention‐deficit/hyperactivity disorder (ADHD), compared with those without ADHD. Model 1: adjusted for sex and year of birth; model 2: adjusted for sex, year of birth, education level, birth country, type 2 diabetes mellitus, obesity, dyslipidemia, sleep problems and heavy smoking; model 3: adjusted for sex, year of birth, education level, birth country, type 2 diabetes mellitus, obesity, dyslipidemia, sleep problems, heavy smoking and psychiatric comorbidities.

References

    1. Faraone SV, Asherson P, Banaschewski T et al. Attention‐deficit/hyperactivity disorder. Nat Rev Dis Primers 2015;1:15020. - PubMed
    1. Davidson MA. Literature review: ADHD in adults: a review of the literature. J Atten Disord 2007;11:628‐41. - PubMed
    1. Sayal K, Prasad V, Daley D et al. ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry 2018;5:175‐86. - PubMed
    1. Kessler RC, Adler L, Barkley R et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716‐23. - PMC - PubMed
    1. Cortese S, Moreira‐Maia CR, St Fleur D et al. Association between ADHD and obesity: a systematic review and meta‐analysis. Am J Psychiatry 2016;173:34‐43. - PubMed